AtriCure to Participate in the 41st Annual J.P. Morgan Healthcare Conference

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference. AtriCure’s management is scheduled to present on Monday,...

Click to view original post